Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients - News Press Release | PharmiWeb.com

Links shared publicly online about this topic.

  • 0
    total visits

Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients - News Press Release | PharmiWeb.com

pharmiweb.com —

Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients - News Press Release | PharmiWeb.com

View full resource at pharmiweb.com

Tags: Urinary System, Overactive Bladder, Overactive Bladder Medication, Senior Health, Toviaz, Pfizer, News, Bladder Dysfunction

  • Share

Most Recently Shared on December 6, 2011 at 9:51 am By:

Bladder_OAB Overactive Bladder

Press Release: Pfizer Inc. (NYSE: PFE) announced today the top-line primary endpoint result for Toviaz (fesotero... http://t.co/fo8VY4FF

4 months ago...

Reply

Retweet

Favorite

Also Shared By:

Urology & Nephrology Urology & Nephrology

Advertisement